Basaglar (insulin glargine) and Lantus (insulin glargine) are brand-name prescription medications. They’re approved by the Food and Drug Administration (FDA) to: improve blood sugar levels in ...

Basaglar (insulin glargine) is a brand-name drug that’s used to help manage blood sugar levels in certain people. ... It’s available in a single-use KwikPen and a single-use Tempo Pen.

Find patient medical information for Insulin Glargine on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings ...

Rezvoglar is supplied as a solution containing 100 Units/mL in 3mL KwikPen single-use prefilled pens. The Rezvoglar KwikPen prefilled pen dials in 1 unit increments. Reference. Rezvoglar. Package ...

Basaglar (insulin glargine) is a brand-name subcutaneous injection that’s prescribed for managing blood sugar levels in certain people. As with other drugs, Basaglar can cause side effects, such ...

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...

Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Katelyn O’Brien, PharmD, BCPS, CDCES, BC-ADM, about situations in which an ultra-long-acting insulin may be a good choice.

A new cheaper biosimilar version of Sanofi's Lantus (insulin ... Abasaglar is priced at £35.28 for both its 100unit/ml 3ml x 5 cartridges and a 100unit/ml 3ml 'KwikPen', while Lantus costs £41. ...